Differential pharmacology and clinical utility of dapagliflozin in type 2 diabetes

Dapagliflozin belongs in the family of sodium-glucose cotransporter 2 (SGLT2) inhibitors and acts by reducing glucose reabsorption in the proximal tubule. The aim of this review is to present the differential pharmacology and clinical utility of dapagliflozin. Dapagliflozin is orally administered, h...

Descripción completa

Detalles Bibliográficos
Autores principales: Papakitsou, Ioanna, Vougiouklakis, George, Elisaf, Moses S, Filippatos, Theodosios D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6756826/
https://www.ncbi.nlm.nih.gov/pubmed/31572020
http://dx.doi.org/10.2147/CPAA.S172353

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6756826/
https://www.ncbi.nlm.nih.gov/pubmed/31572020
http://dx.doi.org/10.2147/CPAA.S172353

Ejemplares similares